Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN
Millennium Management LLC reported a 5.70% stake in Supernus Pharmaceuticals, Inc. (Schedule 13G/A)
Event Feb 11, 2026 · Filed Feb 18, 2026
Millennium Management LLC reported a 5.70% stake in Supernus Pharmaceuticals, Inc., 3,281,615 shares, as a passive investor on Feb 11, 2026. Filed Feb 18, 2026 (Schedule 13G/A).
- Stake
- 5.70%
- Shares
- 3,281,615
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 4.90% | 2,817,883 |
| Millennium Management LLC | 5.70% | 3,281,615 |
| Millennium Group Management LLC | 5.70% | 3,281,615 |
| Israel A. Englander | 5.70% | 3,281,615 |
Source
Related
- Supernus Pharmaceuticals, Inc.
- Millennium Management LLC
- Supernus Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Aug 6, 2026
- Schedule 13G · Millennium Management LLC · Feb 2, 2026
- Form 4 · Khattar Jack A. · Aug 14, 2026
- Form 4 · Rubin Jonathan · Aug 14, 2026
- Form 4 · Bhatt Padmanabh P. · Aug 14, 2026
- Form 4 · Mottola Frank · Aug 14, 2026
- Form 4 · Dec Timothy C · Aug 14, 2026